Gobert A - Search Results

1

The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders.

Millan MJ, Rivet JM, Gobert A. Millan MJ, et al. Among authors: gobert a. J Psychopharmacol. 2016 Nov;30(11):1099-1128. doi: 10.1177/0269881116672342. Epub 2016 Oct 17. J Psychopharmacol. 2016. PMID: 27756833 Review.

2

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.

Millan MJ, Brocco M, Gobert A, Dekeyne A. Millan MJ, et al. Among authors: gobert a. Psychopharmacology (Berl). 2005 Feb;177(4):448-58. doi: 10.1007/s00213-004-1962-z. Epub 2004 Jul 31. Psychopharmacology (Berl). 2005. PMID: 15289999

3

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ. Dekeyne A, et al. Among authors: gobert a. Psychopharmacology (Berl). 2008 Sep;199(4):549-68. doi: 10.1007/s00213-008-1177-9. Epub 2008 Jun 4. Psychopharmacology (Berl). 2008. PMID: 18523738

4

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents.

Millan MJ, Lejeune F, Gobert A. Millan MJ, et al. Among authors: gobert a. J Psychopharmacol. 2000 Jun;14(2):114-38. doi: 10.1177/026988110001400202. J Psychopharmacol. 2000. PMID: 10890307 Review.

5

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.

Dekeyne A, Gobert A, Iob L, Cistarelli L, Melon C, Millan MJ. Dekeyne A, et al. Among authors: gobert a. Psychopharmacology (Berl). 2001 Nov;158(2):213-8. doi: 10.1007/s002130100895. Psychopharmacology (Berl). 2001. PMID: 11702096

6

The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study.

Lejeune F, Gobert A, Millan MJ. Lejeune F, et al. Among authors: gobert a. Brain Res. 2002 May 10;935(1-2):134-9. doi: 10.1016/s0006-8993(02)02476-9. Brain Res. 2002. PMID: 12062484

7

Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.

Dekeyne A, Gobert A, Auclair A, Girardon S, Millan MJ. Dekeyne A, et al. Among authors: gobert a. Psychopharmacology (Berl). 2002 Jul;162(2):156-67. doi: 10.1007/s00213-002-1070-x. Epub 2002 May 1. Psychopharmacology (Berl). 2002. PMID: 12110993

8

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.

Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. Millan MJ, et al. Among authors: gobert a. J Pharmacol Exp Ther. 2004 Jun;309(3):903-20. doi: 10.1124/jpet.103.062398. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978194

9

The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.

Millan MJ, Seguin L, Gobert A, Cussac D, Brocco M. Millan MJ, et al. Among authors: gobert a. Psychopharmacology (Berl). 2004 Jul;174(3):341-57. doi: 10.1007/s00213-003-1770-x. Epub 2004 Feb 19. Psychopharmacology (Berl). 2004. PMID: 14985929

10

The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.

Millan MJ, Gobert A, Roux S, Porsolt R, Meneses A, Carli M, Di Cara B, Jaffard R, Rivet JM, Lestage P, Mocaer E, Peglion JL, Dekeyne A. Millan MJ, et al. Among authors: gobert a. J Pharmacol Exp Ther. 2004 Oct;311(1):190-203. doi: 10.1124/jpet.104.069625. Epub 2004 May 14. J Pharmacol Exp Ther. 2004. PMID: 15146031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page